Eternatear

Developer of medicine for dry eye disease

placeRaleigh, North Carolina, United States calendar_todayFounded 2018 groups2 employees language eternatear.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 364 times.

YearFilings
20201
20211
20221
20231
20242
20251
20261

Investor mix

8 investors on record; lead investors include Carolina Angel Network, Keiretsu Forum.

Investor typeCountShare
Venture capital338%
Private equity113%
Angel & family office338%
Other / undisclosed113%
Coming soon